Summary & Overview
CPT 77761: Intracavitary Brachytherapy Implant Placement
CPT code 77761 denotes intracavitary brachytherapy implant placement of one to four radioactive sources to treat cancers by delivering localized radiation directly in or near the tumor. This procedure is a key modality in radiation oncology, commonly used for prostate cancer and for tumors involving body cavities such as the vagina or lungs. Nationally, brachytherapy implant procedures influence care patterns, resource allocation in radiation oncology departments, and facility utilization.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, common sites of service, and the types of benchmarks typically analyzed for this code, including utilization rates, site-of-service distribution, and payer coverage patterns. The publication also summarizes relevant policy considerations that affect coding and billing for intracavitary brachytherapy, and highlights operational implications for oncology practices and facilities.
This summary provides a national perspective on the clinical role of CPT code 77761, the payers that commonly cover brachytherapy implants, and the areas where payers and providers often focus review and prior authorization efforts. Data not available in the input is noted where applicable elsewhere in the publication.
Billing Code Overview
CPT code 77761 describes a brachytherapy implant procedure in which the provider places one to four radioactive sources inside a body cavity to treat cancer. The procedure delivers localized radiation by positioning implants in or adjacent to a tumor; prostate cancer is the most commonly treated malignancy with this approach. The service type is radiation oncology procedural therapy using intracavitary brachytherapy. The typical site of service includes hospital outpatient departments, ambulatory surgery centers, and radiation oncology clinics where brachytherapy implants are performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old man with localized intermediate-risk prostate adenocarcinoma who presents for brachytherapy implantation. After multidisciplinary review and staging with prostate biopsy and MRI, the radiation oncology team schedules implantation of radioactive seeds to deliver high-dose-rate or low-dose-rate radiation directly into the prostate. The workflow includes pre-procedure imaging and treatment planning, informed consent, anesthesia (local with sedation or general), transrectal ultrasound or CT guidance for catheter and applicator placement, placement of one to four radioactive sources or multiple seeds into the prostate gland, intraoperative dosimetry verification, and postoperative instructions for activity restrictions and radiation safety. Typical monitoring includes recovery from anesthesia, assessment for urinary retention or bleeding, and outpatient follow-up with radiation oncology and urology for PSA surveillance and management of urinary or rectal side effects.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Use when no other modifier applies and the service is reported normally |
11 | Rebilling/Adjusted Services |